Agilent Technologies Honors Australian Researcher with 2007 Manfred Donike Award for Research on Sports Doping
Agilent Technologies Inc. announced it has presented its 2007 Manfred Donike Award for scientific excellence in doping control to Australian researcher Adam Cawley, a chemist at the National Measurement Institute of Australia. Cawley, who is also a doctoral student at the University of Sydney's School of Chemistry, was honored for his research on the diagnostic value of specific urine-sample screening markers for endogenous steroid abuse in athletes.
Agilent sponsors this annual award, first presented in 1997, to recognize distinguished scientific contributions in the field of sports medicine. Award winners are scientists who exemplify the spirit and scientific leadership of doping-control pioneer Manfred Donike, and whose contributions significantly advance the cause of fairness in sports competition.
Marie-Theres Donike, wife of the late professor, and Stephen B. Crisp, international business development manager for Agilent's Life Sciences and Chemical Analysis business, presented the award March 1 at the 25th Annual Manfred Donike Doping Control Workshop in Cologne, Germany.
"Sports doping labs routinely look in urine samples for high levels of steroid types that either are not normally present in urine or are naturally present at very low concentrations," said Crisp. "Cawley's research asks the question, 'How great is the diagnostic value of these markers, and is there a better way?'"
Cawley collaborated with other researchers, including Ray Kazlauskas and Graham Trout of the National Measurement Institute of Australia, Adrian George of the University of Sydney's School of Chemistry, and Robert Weatherby and Sonya Marshall-Gradisnik of Southern Cross University, Lismore, Australia.
Cawley's doctoral studies involve working as a research scientist with the Australian Sports Drug Testing Laboratory to develop methods of analysis capable of detecting steroid abuse in athletes. A member of the World Association of Anti-Doping Scientists, he served as an endogenous steroid analyst for the Sydney 2000 Olympic Games and the Torino 2006 Winter Olympic Games. He holds a B.Sc. with honors from the University of Sydney.
Source: Agilent Technologies
More news from this company
- Agilent Opens Spectroscopy Technology Innovation Center (09/04/2013)
- Agilent to Acquire Dako for $2.2 Billion (05/25/2012)
- Agilent Technologies Awards 2011 Russell Varian Prize for Innovation in Nuclear Magnetic Resonance (10/04/2011)
- Agilent Technologies Acquires Lab901 to Expand Electrophoresis Portfolio for Molecular Biology Applications (03/08/2011)
- Agilent Opens Global Manufacturing Facility for Life Sciences Instruments (11/05/2010)